Regulation of Neutrophil Degranulation and Cytokine Secretion: A Novel Model Approach Based on Linear Fitting

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Naegelen, Isabelle ^a   Beaume, Nicolas ^a   Plançon, Sébastien ^a   Schenten, Véronique ^a   Tschirhart, Eric J ^a   Bréchard, Sabrina ^a  

^a UNIVERSITY OF LUXEMBOURG   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; CYTOKINE; INTERLEUKIN 12P40; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; MEMBRANE ANTIGEN;

ARTICLE; ATHEROSCLEROSIS; CELL ISOLATION; CELL STIMULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE RELEASE; DEGRANULATION; EXOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; NEUTROPHIL; RHEUMATOID ARTHRITIS; BIOLOGICAL MODEL; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; PHENOTYPE; TIME FACTOR;

ANTIGENS, SURFACE; CELL DEGRANULATION; CYTOKINES; HUMANS; IMMUNOPHENOTYPING; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MODELS, BIOLOGICAL; NEUTROPHILS; PHENOTYPE; TIME FACTORS;

EID: 84947087517     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/817038     Document Type: Article

References (46)

1. C. Nathan, "Neutrophils and immunity: challenges and opportunities," Nature Reviews Immunology, vol. 6, no. 3, pp. 173-182, 2006.
2. S. Pellmé, M. Mörgelin, H. Tapper, U.-H. Mellqvist, C. Dahlgren, and A. Karlsson, "Localization of human neutrophil interleukin-8 (CXCL-8) to organelle(s) distinct from the classical granules and secretory vesicles," Journal of Leukocyte Biology, vol. 79, no. 3, pp. 564-573, 2006.
3. M. A. Cassatella, "The production of cytokines by polymorphonuclear neutrophils," Immunology Today, vol. 16, no. 1, pp. 21-26, 1995.
4. P. Scapini, J.A. Lapinet-Vera, S. Gasperini, F.Calzetti, F. Bazzoni, and M. A. Cassatella, "The neutrophil as a cellular source of chemokines," Immunological Reviews, vol. 177, pp. 195-203, 2000.
5. T. Kasama, Y. Miwa, T. Isozaki, T. Odai, M. Adachi, and S. L. Kunkel, "Neutrophil-derived cytokines: potential therapeutic targets in inflammation," Current Drug Targets: Inflammation and Allergy, vol. 4, no. 3, pp. 273-279, 2005.
6. A. C. Stanley and P. Lacy, "Pathways for cytokine secretion," Physiology, vol. 25, no. 4, pp. 218-229, 2010.
7. E. H. Duitman, Z. Orinska, and S. Bulfone-Paus, "Mechanisms of cytokine secretion: a portfolio of distinct pathways allows flexibility in cytokine activity," European Journal of Cell Biology, vol. 90, no. 6-7, pp. 476-483, 2011.
8. E. Crivellato, B.Nico, F.Mallardi, C. A. Beltrami, and D. Ribatti, "Piecemeal degranulation as a general secretory mechanism?" Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, vol. 274, no. 1, pp. 778-784, 2003.
9. R. Moqbel and J. J. Coughlin, "Differential secretion of cytokines," Science Signaling, vol. 2006, no. 338, article pe26, 2006.
10. J. A. Pickett and J. M. Edwardson, "Compound exocytosis: mechanisms and functional significance," Traffic, vol. 7, no. 2, pp. 109-116, 2006.
11. A. Matsukawa and M. Yoshinaga, "Sequential generation of cytokines during the initiative phase of inflammation, with reference to neutrophils," Inflammation Research, vol. 47, supplement 3, pp. S137-S144, 1998.
12. G. Radford-Smith and D. P. Jewell, "Cytokines and inflammatory bowel disease," Bailliere's Clinical Gastroenterology, vol. 10, no. 1, pp. 151-164, 1996.
13. S. W. Edwards and M. B. Hallett, "Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis," Immunology Today, vol. 18, no. 7, pp. 320-324, 1997.
14. W. Q. Gan, S. F. P. Man, A. Senthilselvan, and D. D. Sin, "Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a metaanalysis," Thorax, vol. 59, no. 7, pp. 574-580, 2004.
15. O. Soehnlein, "Multiple roles for neutrophils in atherosclerosis," Circulation Research, vol. 110, no. 6, pp. 875-888, 2012.
16. T.W. Kuijpers, A. T. J. Tool, C. E. Van der Schoot et al., "Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation," Blood, vol. 78, no. 4, pp. 1105-1111, 1991.
17. I. Naegelen, S. Plançon, N. Nicot et al., "An essential role of syntaxin 3 protein for granule exocytosis and secretion of IL-1α, IL-1β, IL-12b, and CCL4 from differentiated HL-60 cells," Journal of Leukocyte Biology, vol. 97, no. 3, pp. 557-571, 2015.
18. T. Billiet, P. Rutgeerts, M. Ferrante, G. Van Assche, and S. Vermeire, "Targeting TNF-alpha for the treatment of inflammatory bowel disease," ExpertOpinion on BiologicalTherapy, vol. 14,no. 1, pp. 75-101, 2014.
19. Y. Zhang, X. Yang, F. Bian et al., "TNF-α promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells: crosstalk between NF-κB and PPAR-γ," Journal of Molecular and Cellular Cardiology, vol. 72, pp. 85-94, 2014.
20. Y. Li, Z. Zhang, Y. Xu, S.Xiong,W.Ni, and S.Chen, "TNF-α upregulates matrix metalloproteinase-9 expression and activity in alveolar macrophages from patients with chronic obstructive pulmonary disease," Journal of Huazhong University of Science and Technology, vol. 26, no. 6, pp. 647-650, 2006.
21. W.Hueber, B. H. Tomooka, X. Zhao et al., "Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines," Annals of the Rheumatic Diseases, vol. 66, no. 6, pp. 712-719, 2007.
22. O. Ludwiczek, E. Vannier, I. Borggraefe et al., "Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease," Clinical and Experimental Immunology, vol. 138, no. 2, pp. 323-329, 2004.
23. J.Hartman andW. H. Frishman, "Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy," Cardiology in Review, vol. 22, no. 3, pp. 147-151, 2014.
24. R. Garrod, J. Marshall, E. Barley, S. Fredericks, and G. Hagan, "The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD)," Primary Care Respiratory Journal, vol. 16, no. 4, pp. 236-240, 2007.
25. K. Vandenbroeck, I. Alloza, M. Gadina, and P.Matthys, "Inhibiting cytokines of the interleukin-12 family: recent advances and novel challenges," Journal of Pharmacy and Pharmacology, vol. 56, no. 2, pp. 145-160, 2004.
26. C. Schmidt, T.Marth, B. M.Wittig,A.Hombach,H.Abken, and A. Stallmach, "Interleukin-12 antagonists as new therapeutic agents in inflammatory bowel disease," Pathobiology, vol. 70,no. 3, pp. 177-183, 2003.
27. K. Yong, G. Dogra, N. Boudville et al., "Interleukin-12 is associated with arterial stiffness in healthy individuals," American Journal of Hypertension, vol. 26, no. 2, pp. 159-162, 2013.
28. R. E. Gerszten, E. A. Garcia-Zepeda, Y.-C. Lim et al., "MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions," Nature, vol. 398, no. 6729, pp. 718-725, 1999.
29. S. R. Chintalacharuvu, J. X. Wang, J. M. Giaconia, and C. Venkataraman, "An essential role for CCL3 in the development of collagen antibody-induced arthritis," Immunology Letters, vol. 100, no. 2, pp. 202-204, 2005.
30. W. A. Kuziel, T. C. Dawson, M. Quinones et al., "CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice," Atherosclerosis, vol. 167, no. 1, pp. 25-32, 2003.
31. E. Robinson, E. C. Keystone, T. J. Schall, N. Gillett, and E. N. Fish, "Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1β production by synovial T cells," Clinical & Experimental Immunology, vol. 101, no. 3, pp. 398-407, 1995.
32. C. Banks, A. Bateman, R. Payne, P. Johnson, and N. Sheron, "Chemokine expression in IBD.Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease," Journal of Pathology, vol. 199, no. 1, pp. 28-35, 2003.
33. T.-C. Yao, M.-L. Kuo, L.-C. See et al., "RANTES and monocyte chemoattractant protein 1 as sensitive markers of disease activity in patients with juvenile rheumatoid arthritis: a six-year longitudinal study," Arthritis and Rheumatism, vol. 54, no. 8, pp. 2585-2593, 2006.
34. K. Mitsuyama, A. Toyonaga, E. Sasaki et al., "IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease," Clinical and Experimental Immunology, vol. 96, no. 3, pp. 432-436, 1994.
35. N. Borregaard and J. B. Cowland, "Granules of the human neutrophilic polymorphonuclear leukocyte," Blood, vol. 89, no. 10, pp. 3503-3521, 1997.
36. J. Ernst and Z. Bar-Joseph, "STEM: a tool for the analysis of short time series gene expression data," BMC Bioinformatics, vol. 7, article 191, 2006.
37. V.Witko-Sarsat, P. Rieu,B.Descamps-Latscha, P. Lesavre, andL. Halbwachs-Mecarelli, "Neutrophils: molecules, functions and pathophysiological aspects," Laboratory Investigation, vol. 80, no. 5, pp. 617-653, 2000.
38. K. C. Malcolm and G. S.Worthen, "Lipopolysaccharide stimulates p38-dependent induction of antiviral genes in neutrophils independently of paracrine factors," The Journal of Biological Chemistry, vol. 278, no. 18, pp. 15693-15701, 2003.
39. M. A. Cassatella, L. Meda, S. Bonora, M. Ceska, and G. Constantin, "Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide," Journal of Experimental Medicine, vol. 178, no. 6, pp. 2207-2211, 1993.
40. P. E.Van den Steen, P. Proost, A. Wuyts, J. VanDamme, and G. Opdenakker, "Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-α and leaves RANTES and MCP-2 intact," Blood, vol. 96, no. 8, pp. 2673-2681, 2000.
41. P. D. Terebuh, I. G. Otterness, R. M. Strieter et al., "Biologic and immunohistochemical analysis of interleukin-6 expression in vivo. Constitutive and induced expression in murine polymorphonuclear and mononuclear phagocytes," The American Journal of Pathology, vol. 140, no. 3, pp. 649-657, 1992.
42. C. Eder, "Mechanisms of interleukin-1β release," Immunobiology, vol. 214, no. 7, pp. 543-553, 2009.
43. K. D. Metzler, T. A. Fuchs, W. M. Nauseef et al., "Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity," Blood, vol. 117, no. 3, pp. 953-959, 2011.
44. C. Pasquali, I. Fialka, and L. A. Huber, "Subcellular fractionation, electromigration analysis and mapping of organelles," Journal of Chromatography B: Biomedical Sciences and Applications, vol. 722, no. 1-2, pp. 89-102, 1999.
45. S. Rørvig, O. Østergaard, N. H. H. Heegaard, and N. Borregaard, "Proteome profiling of human neutrophil granule subsets, secretory vesicles, and cell membrane: correlation with transcriptome profiling of neutrophil precursors," Journal of Leukocyte Biology, vol. 94, no. 4, pp. 711-721, 2013.
46. B.A.Kidd, L. A. Peters,E.E. Schadt, and J.T.Dudley, "Unifying immunology with informatics and multiscale biology," Nature Immunology, vol. 15, no. 2, pp. 118-127, 2014.